Sgiggle

Capnia Inc, based in Palo Alto, CA, specializes in innovative healthcare solutions aimed at improving newborn health, particularly in jaundice management. Their flagship product, the CoSense ETCOc Monitor, offers a non-invasive method for the early detection and measurement of hemolysis and neurotoxic risk in newborns, revolutionizing how neonatal jaundice is diagnosed and managed. By utilizing end-tidal carbon monoxide (ETCOc) testing, Capnia's technology enables healthcare providers to accurately assess the risk of hyperbilirubinemia and kernicterus in newborns prior to discharge. This groundbreaking approach aims to reduce readmissions, unnecessary interventions, and ultimately improve health outcomes for vulnerable infants. Generated from the website